Magdalene K. Sgagias

Array ( [id] => 7374725 [patent_doc_number] => 20040093623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Non-human animal disease models' [patent_app_type] => new [patent_app_number] => 10/450873 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9361 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20040093623.pdf [firstpage_image] =>[orig_patent_app_number] => 10450873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6971301 [patent_doc_number] => 20050037011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Diagnosing and treating hematopoietic cancers' [patent_app_type] => utility [patent_app_number] => 10/719054 [patent_app_country] => US [patent_app_date] => 2003-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20903 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037011.pdf [firstpage_image] =>[orig_patent_app_number] => 10719054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7473662 [patent_doc_number] => 20040121942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure' [patent_app_type] => new [patent_app_number] => 10/705791 [patent_app_country] => US [patent_app_date] => 2003-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9954 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121942.pdf [firstpage_image] =>[orig_patent_app_number] => 10705791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851735 [patent_doc_number] => 20060234926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Nucleic acid ligands and uses therefor' [patent_app_type] => utility [patent_app_number] => 10/533979 [patent_app_country] => US [patent_app_date] => 2003-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9785 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234926.pdf [firstpage_image] =>[orig_patent_app_number] => 10533979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7069585 [patent_doc_number] => 20050244970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Stem cell libraries' [patent_app_type] => utility [patent_app_number] => 10/516605 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 28723 [patent_no_of_claims] => 241 [patent_no_of_ind_claims] => 203 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244970.pdf [firstpage_image] =>[orig_patent_app_number] => 10516605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7296046 [patent_doc_number] => 20040214234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Method' [patent_app_type] => new [patent_app_number] => 10/297106 [patent_app_country] => US [patent_app_date] => 2003-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11774 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214234.pdf [firstpage_image] =>[orig_patent_app_number] => 10297106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786530 [patent_doc_number] => 20060205688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Method of modulating epithelial cell activity by modulating the functional levels of sphingosine kinase' [patent_app_type] => utility [patent_app_number] => 10/531626 [patent_app_country] => US [patent_app_date] => 2003-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18070 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205688.pdf [firstpage_image] =>[orig_patent_app_number] => 10531626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7280373 [patent_doc_number] => 20040062750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Use of mullerian inhibiting substance for treating excess androgen states' [patent_app_type] => new [patent_app_number] => 10/683346 [patent_app_country] => US [patent_app_date] => 2003-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14403 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20040062750.pdf [firstpage_image] =>[orig_patent_app_number] => 10683346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5830893 [patent_doc_number] => 20060064771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Procedure of genetic recombination for galinaceae hybrids breeding' [patent_app_type] => utility [patent_app_number] => 10/539259 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3966 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20060064771.pdf [firstpage_image] =>[orig_patent_app_number] => 10539259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127876 [patent_doc_number] => 20050059620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Promoter driven tissue specific cytotoxic agents and title methods of use' [patent_app_type] => utility [patent_app_number] => 10/656450 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19996 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059620.pdf [firstpage_image] =>[orig_patent_app_number] => 10656450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7452763 [patent_doc_number] => 20040268424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Porcine animals lacking any expression of functional alpha 1, 3 galactosyltransferase' [patent_app_type] => new [patent_app_number] => 10/646970 [patent_app_country] => US [patent_app_date] => 2003-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21353 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20040268424.pdf [firstpage_image] =>[orig_patent_app_number] => 10646970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7010674 [patent_doc_number] => 20050064390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Cells expressing both human CD4 and a human fusion accessory factor associated with HIV infection' [patent_app_type] => utility [patent_app_number] => 10/638797 [patent_app_country] => US [patent_app_date] => 2003-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11223 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20050064390.pdf [firstpage_image] =>[orig_patent_app_number] => 10638797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7134963 [patent_doc_number] => 20040043487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Method of constructing vectors for homologous recombination directed mutagenesis' [patent_app_type] => new [patent_app_number] => 10/636822 [patent_app_country] => US [patent_app_date] => 2003-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5492 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043487.pdf [firstpage_image] =>[orig_patent_app_number] => 10636822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7221350 [patent_doc_number] => 20040072344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Method for inducing differentiation of embryonic stem cells into functioning cells' [patent_app_type] => new [patent_app_number] => 10/626772 [patent_app_country] => US [patent_app_date] => 2003-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8953 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072344.pdf [firstpage_image] =>[orig_patent_app_number] => 10626772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122992 [patent_doc_number] => 20050014821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Compounds and methods for treating neurodegenerative disorders' [patent_app_type] => utility [patent_app_number] => 10/625986 [patent_app_country] => US [patent_app_date] => 2003-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 29489 [patent_no_of_claims] => 100 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10625986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7466191 [patent_doc_number] => 20040198681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'MB-1 analogs and uses thereof' [patent_app_type] => new [patent_app_number] => 10/625882 [patent_app_country] => US [patent_app_date] => 2003-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 17316 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198681.pdf [firstpage_image] =>[orig_patent_app_number] => 10625882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7398515 [patent_doc_number] => 20040018626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Methods of modifying eukaryotic cells' [patent_app_type] => new [patent_app_number] => 10/624044 [patent_app_country] => US [patent_app_date] => 2003-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14483 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20040018626.pdf [firstpage_image] =>[orig_patent_app_number] => 10624044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7221326 [patent_doc_number] => 20040072342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Production and use of microvessels in fibronectin-containing gel' [patent_app_type] => new [patent_app_number] => 10/297321 [patent_app_country] => US [patent_app_date] => 2003-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 29517 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072342.pdf [firstpage_image] =>[orig_patent_app_number] => 10297321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7019460 [patent_doc_number] => 20050221479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Process for producing nerve cells' [patent_app_type] => utility [patent_app_number] => 10/518749 [patent_app_country] => US [patent_app_date] => 2003-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 18927 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20050221479.pdf [firstpage_image] =>[orig_patent_app_number] => 10518749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7399846 [patent_doc_number] => 20040023356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Wise/Sost nucleic acid sequences and amino acid sequences' [patent_app_type] => new [patent_app_number] => 10/464368 [patent_app_country] => US [patent_app_date] => 2003-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 37125 [patent_no_of_claims] => 235 [patent_no_of_ind_claims] => 73 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023356.pdf [firstpage_image] =>[orig_patent_app_number] => 10464368 [rel_patent_id] =>[rel_patent_doc_number] =>)